The Role of Adipocytokines and their Receptors in Prostate Cancer: Adiponectin May Protect Against Progression
Anticancer Research · 2024
DOI: 10.21873/anticanres.16933 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Eiji Kashiwagi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan; eiji.pma@gmail.com. Hauptthemen laut MEDLINE: Leptin, Prostatic Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan; eiji.pma@gmail.com.
- Department of Urology and Renal Transplantation, Yokohama City University Medical Center, Yokohama, Japan.
- Department of Urology, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan.
- Departments of Pathology & Laboratory Medicine and Urology, and James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, U.S.A.
Zitieren
APA
Kashiwagi, E., Kawahara, T., Kinoshita, F., Shiota, M., Inokuchi, J., Miyamoto, H., & Eto, M. (2024). The Role of Adipocytokines and their Receptors in Prostate Cancer: Adiponectin May Protect Against Progression. Anticancer Research. https://doi.org/10.21873/anticanres.16933
Vancouver
Kashiwagi E, Kawahara T, Kinoshita F, Shiota M, Inokuchi J, Miyamoto H, et al. The Role of Adipocytokines and their Receptors in Prostate Cancer: Adiponectin May Protect Against Progression. Anticancer Research. 2024. doi:10.21873/anticanres.16933
BibTeX
@article{Kashiwagi2024,
author = {Kashiwagi, Eiji and Kawahara, Takashi and Kinoshita, Fumio and Shiota, Masaki and Inokuchi, Junichi and Miyamoto, Hiroshi and Eto, Masatoshi},
title = {The Role of Adipocytokines and their Receptors in Prostate Cancer: Adiponectin May Protect Against Progression},
journal = {Anticancer Research},
year = {2024},
doi = {10.21873/anticanres.16933}
}
EUVIMED